Kazia Therapeutics (KZIA) Assets (2009 - 2025)
Kazia Therapeutics' (KZIA) quarterly Assets came in at $46.7 million in Q4 2025, up 298.6% YoY from $11.7 million in Q4 2024, and up 1103.12% on a QoQ basis from $3.9 million in Q2 2025.
Kazia Therapeutics (KZIA) Assets (2009 - 2025) Analysis & Trends
Kazia Therapeutics (KZIA) has 17 years of Assets data on file, last reported at $46.7 million in Q4 2025.
- Quarterly Assets rose 298.6% year-over-year to $46.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $46.7 million (up 298.6% YoY) and the FY2025 annual result came in at $3.9 million, down 72.72% from the prior year.
- Assets rose to $46.7 million in Q4 2025, from $3.9 million in the prior quarter.
- In the past five years, Assets ranged from a high of $46.7 million in Q4 2025 to a low of $3.9 million in Q2 2025.
- A 5-year average of $23.1 million and a median of $18.5 million in 2022 frame the typical range for Assets.
- The widest YoY moves for Assets: up 298.6% in 2025, down 72.72% in 2025.
- Tracing KZIA's Assets over 5 years: stood at $32.5 million in 2021, then plunged by 43.8% to $18.3 million in 2022, then slipped by 13.21% to $15.9 million in 2023, then dropped by 26.21% to $11.7 million in 2024, then surged by 298.6% to $46.7 million in 2025.
- The last three Assets figures came in at $46.7 million (Q4 2025), $3.9 million (Q2 2025), and $11.7 million (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.03 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.32 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 9.18 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 15.59 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.56 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.10 Bn |
| 10 | Kazia Therapeutics | 4.22 Bn | 4.22 Bn | - | 46.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 46.69 Mn |
| Jun 30, 2025 | 3.88 Mn |
| Dec 31, 2024 | 11.71 Mn |
| Jun 30, 2024 | 14.23 Mn |
| Dec 31, 2023 | 15.87 Mn |
| Jun 30, 2023 | 18.77 Mn |
| Dec 31, 2022 | 18.29 Mn |
| Jun 30, 2022 | 24.39 Mn |
| Dec 31, 2021 | 32.54 Mn |
| Jun 30, 2021 | 44.73 Mn |
| Dec 31, 2020 | 28.96 Mn |
| Jun 30, 2020 | 15.12 Mn |
| Dec 31, 2019 | 14.01 Mn |
| Jun 30, 2019 | 14.83 Mn |
| Dec 31, 2018 | 18.36 Mn |
| Jun 30, 2018 | 21.33 Mn |
| Jun 30, 2017 | 26.98 Mn |
| Dec 31, 2016 | 28.37 Mn |
| Jun 30, 2016 | 26.81 Mn |
| Dec 31, 2015 | 33.21 Mn |